IBAC — IB Acquisition Corp.
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1998781 ·
Last close
$10.88
Market Cap
$54.49M
52W High
$11.64
52W Low
$10.19
ADV30
2,387
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -624,429 | -567,166 | 8,518,014 | 30,161 | 2,447,413 |
| Mar 2026 | 0 | — | -748,177 | -639,866 | 8,477,425 | 4,634 | 1,839,658 |
| Dec 2025 | 0 | — | -180,000 | -58,902 | 16,405,261 | 165,484 | 1,162,171 |
| Sep 2025 | 0 | — | -236,772 | 866,365 | 17,134,092 | 428,700 | 1,832,100 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,515,107
Investing CF
$114,909,982
Financing CF
$-114,017,616
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.02
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,688,791
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-1,337,159
Pretax Income TTM
$1,462,273
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 0 | -748,908 | 3,416,169 | 17,134,092 | 1,832,100 | 15,301,992 | -1,318,100 |
| Sep 2024 | 0 | -523,974 | 1,867,387 | 119,800,388 | 722,230 | 119,078,158 | -820,959 |
| Sep 2023 | 0 | -6,844 | -6,844 | 52,553 | 57,987 | -5,434 | -207 |
| Sep 2022 | 0 | -578 | -578 | 2,760 | 1,350 | 1,410 | -128 |
TTM Snapshot
Revenues TTM
$-2,621,671
NetIncome TTM
$986,207
OpCashFlow TTM
—
Assets (Latest)
$8,477,425
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ICCC | IMMUCELL CORP /DE/ | $88.55M | $9.75 | — |
| MXCT | MAXCYTE, INC. | $105.27M | $1.02 | — |
| IMDX | Insight Molecular Diagnostics Inc. | $107.34M | $3.28 | — |
| NNNN | Anbio Biotechnology | $202.78M | $4.62 | — |
| AWHL | Aspira Women's Health Inc. | $10.54M | $0.23 | — |
News headlines (Yahoo Finance, 1h cache)
GNQ Insilico Inc. to go Public Through Business Combination With IB Acquisition Corp. (NASDAQ: IBAC)
2026-03-16 17:45 · Yahoo
With 65% institutional ownership, IB Acquisition Corp. (NASDAQ:IBAC) is a favorite amongst the big guns
2025-11-01 13:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.